交易 Vertex Pharmaceuticals Incorporated - VRTX CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.45 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Vertex Pharmaceuticals Inc ESG Risk Ratings
High Medium Low Negligible
“B”分數表示相對 ESG 表現良好,公開報告重要 ESG 數據的透明度高於平均水平。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 18, 2024 | 393.14 | -0.51 | -0.13% | 393.65 | 395.95 | 390.24 |
Apr 17, 2024 | 392.90 | 0.41 | 0.10% | 392.49 | 397.76 | 391.96 |
Apr 16, 2024 | 393.75 | -1.51 | -0.38% | 395.26 | 398.24 | 392.04 |
Apr 15, 2024 | 397.32 | -2.39 | -0.60% | 399.71 | 402.09 | 396.50 |
Apr 12, 2024 | 396.41 | -0.55 | -0.14% | 396.96 | 399.96 | 393.34 |
Apr 11, 2024 | 399.74 | -3.18 | -0.79% | 402.92 | 403.52 | 398.35 |
Apr 10, 2024 | 397.31 | -1.02 | -0.26% | 398.33 | 399.63 | 394.48 |
Apr 9, 2024 | 404.13 | -0.69 | -0.17% | 404.82 | 405.73 | 398.82 |
Apr 8, 2024 | 403.77 | 2.57 | 0.64% | 401.20 | 404.45 | 397.17 |
Apr 5, 2024 | 406.39 | 4.07 | 1.01% | 402.32 | 409.75 | 399.95 |
Apr 4, 2024 | 403.49 | -6.55 | -1.60% | 410.04 | 411.75 | 402.58 |
Apr 3, 2024 | 408.69 | 0.50 | 0.12% | 408.19 | 414.73 | 404.45 |
Apr 2, 2024 | 409.31 | -9.82 | -2.34% | 419.13 | 420.15 | 406.49 |
Apr 1, 2024 | 420.13 | 0.35 | 0.08% | 419.78 | 421.13 | 413.61 |
Mar 28, 2024 | 417.95 | 1.29 | 0.31% | 416.66 | 420.33 | 411.89 |
Mar 27, 2024 | 417.17 | -1.17 | -0.28% | 418.34 | 419.69 | 412.13 |
Mar 26, 2024 | 418.31 | 2.42 | 0.58% | 415.89 | 419.26 | 414.42 |
Mar 25, 2024 | 415.77 | 1.98 | 0.48% | 413.79 | 418.08 | 413.79 |
Mar 22, 2024 | 415.60 | -0.72 | -0.17% | 416.32 | 417.25 | 411.66 |
Mar 21, 2024 | 415.68 | 0.83 | 0.20% | 414.85 | 418.98 | 413.20 |
Vertex Pharmaceuticals Incorporated Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Monday, May 6, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 Q1 2024 Vertex Pharmaceuticals Inc Earnings Release Q1 2024 Vertex Pharmaceuticals Inc Earnings ReleaseForecast(預報) -返回 - |
時間 (UTC) 20:30 | 國家 US
| 事件 Q1 2024 Vertex Pharmaceuticals Inc Earnings Call Q1 2024 Vertex Pharmaceuticals Inc Earnings CallForecast(預報) -返回 - |
Wednesday, May 15, 2024 | ||
時間 (UTC) 13:00 | 國家 US
| 事件 Vertex Pharmaceuticals Inc Annual Shareholders Meeting Vertex Pharmaceuticals Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Thursday, May 16, 2024 | ||
時間 (UTC) 13:00 | 國家 US
| 事件 Vertex Pharmaceuticals Inc Annual Shareholders Meeting Vertex Pharmaceuticals Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Tuesday, July 30, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q2 2024 Vertex Pharmaceuticals Inc Earnings Release Q2 2024 Vertex Pharmaceuticals Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 8930.7 | 7574.4 | 6205.68 | 4162.82 | 3047.6 |
收入 | 8930.7 | 7574.4 | 6205.68 | 4162.82 | 3047.6 |
收入成本,共計 | 1080.3 | 904.2 | 736.3 | 547.758 | 409.539 |
毛利 | 7850.4 | 6670.2 | 5469.38 | 3615.06 | 2638.06 |
總營業費用 | 4623.3 | 4792.3 | 3349.39 | 2965.25 | 2412.45 |
銷售/一般/行政費用,總計 | 944.7 | 840.1 | 770.456 | 658.498 | 557.616 |
研究與開發 | 2642.8 | 3051.1 | 1829.54 | 1754.54 | 1416.48 |
異常費用(收入) | 13 | 0 | 0 | 28.816 | |
Other Operating Expenses, Total | -57.5 | -3.1 | 13.1 | 4.459 | |
營業收入 | 4307.4 | 2782.1 | 2856.29 | 1197.57 | 635.15 |
利息收入(費用),非經營淨值 | -59.3 | -39.5 | 100.255 | 10.014 | -33.496 |
其他,淨值 | -15.7 | -12.2 | 160.253 | 187.339 | -1.413 |
稅前淨收入 | 4232.4 | 2730.4 | 3116.8 | 1394.92 | 600.241 |
稅後淨收入 | 3322 | 2342.1 | 2711.65 | 1176.81 | 527.103 |
少數股東權益 | 0 | 0 | 9.793 | ||
未計算非常項目前的淨收益 | 3322 | 2342.1 | 2711.65 | 1176.81 | 536.896 |
非常規項目總計 | 1560 | ||||
淨收入 | 3322 | 2342.1 | 2711.65 | 1176.81 | 2096.9 |
普通股股東可獲收益 (不含非經常性項目) | 3322 | 2342.1 | 2711.65 | 1176.81 | 536.395 |
普通股股東可獲收益 (含非經常性項目) | 3322 | 2342.1 | 2711.65 | 1176.81 | 2096.4 |
攤薄淨收入 | 3322 | 2342.1 | 2711.65 | 1176.81 | 2096.4 |
攤薄後加權平均股 | 259.1 | 259.9 | 263.396 | 260.673 | 259.185 |
扣除特別項目的每股攤薄盈利 | 12.8213 | 9.01154 | 10.2949 | 4.51451 | 2.06954 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常攤薄盈利 | 12.8607 | 9.01154 | 10.2949 | 4.51451 | 2.16718 |
Total Adjustments to Net Income | 0 | -0.501 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 2493.2 | 2374.8 | 2302.7 | 2334.3 | 2196.2 |
收入 | 2493.2 | 2374.8 | 2302.7 | 2334.3 | 2196.2 |
收入成本,共計 | 308.6 | 266.9 | 283.3 | 289.4 | 261.8 |
毛利 | 2184.6 | 2107.9 | 2019.4 | 2044.9 | 1934.4 |
總營業費用 | 1466.8 | 1595.8 | 1269.2 | 1207.6 | 1089.9 |
銷售/一般/行政費用,總計 | 262.6 | 241.1 | 267.4 | 246.8 | 215.3 |
研究與開發 | 896.2 | 1089.7 | 716.7 | 674 | 649 |
異常費用(收入) | 0 | 0 | 13 | ||
營業收入 | 1026.4 | 779 | 1033.5 | 1126.7 | 1106.3 |
利息收入(費用),非經營淨值 | 142.7 | 117.6 | 68.4 | 49.2 | -88 |
其他,淨值 | -7.6 | -5.1 | -25.1 | 0.5 | 6.1 |
稅前淨收入 | 1161.5 | 891.5 | 1076.8 | 1176.4 | 1024.4 |
稅後淨收入 | 915.7 | 699.8 | 818.9 | 930.5 | 810.5 |
未計算非常項目前的淨收益 | 915.7 | 699.8 | 818.9 | 930.5 | 810.5 |
淨收入 | 915.7 | 699.8 | 818.9 | 930.5 | 810.5 |
普通股股東可獲收益 (不含非經常性項目) | 915.7 | 699.8 | 818.9 | 930.5 | 810.5 |
普通股股東可獲收益 (含非經常性項目) | 915.7 | 699.8 | 818.9 | 930.5 | 810.5 |
攤薄淨收入 | 915.7 | 699.8 | 818.9 | 930.5 | 810.5 |
攤薄後加權平均股 | 260.4 | 260.3 | 260.3 | 259.5 | 258.7 |
扣除特別項目的每股攤薄盈利 | 3.51651 | 2.68844 | 3.14599 | 3.58574 | 3.13297 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | 3.51651 | 2.68844 | 3.14599 | 3.58574 | 3.17273 |
Other Operating Expenses, Total | -0.6 | -1.9 | 1.8 | -2.6 | -49.2 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 13234.8 | 9560.6 | 8133.38 | 4822.83 | 3843.11 |
現金和短期投資 | 10778.5 | 7524.9 | 6658.9 | 3808.29 | 3168.24 |
現金等價物 | 10504 | 6795 | 5988.19 | 3109.32 | 2650.13 |
短期投資 | 274.5 | 729.9 | 670.71 | 698.972 | 518.108 |
應收賬款總額,淨額 | 1442.2 | 1136.8 | 885.352 | 633.518 | 414.87 |
應收賬款 - 貿易,淨額 | 1442.2 | 1136.8 | 885.352 | 633.518 | 409.688 |
總庫存 | 460.6 | 353.1 | 280.777 | 167.502 | 124.36 |
預付的費用 | 553.5 | 545.8 | 308.353 | 203.79 | 55.022 |
其他流動資産,總計 | 9.725 | 80.615 | |||
總資産 | 18150.9 | 13432.5 | 11751.8 | 8318.46 | 6245.9 |
物業/廠房/設備,總計 - 淨額 | 1455.8 | 1424.4 | 1284.1 | 833.282 | 812.005 |
物業/廠房/設備,總計 - 總額 | 2483.1 | 2320.4 | 2074.68 | 1525.82 | 1263.45 |
累計折舊,總計 | -1027.3 | -896 | -790.58 | -692.54 | -451.443 |
商譽,淨額 | 1088 | 1002.2 | 1002.16 | 1002.16 | 50.384 |
無形資産,淨額 | 603.6 | 400 | 400 | 400 | 0 |
長期投資 | 98.6 | 85.8 | 20.8 | ||
應收票據 - 長期 | |||||
其他長期資産,總計 | 1670.1 | 959.5 | 911.373 | 1260.2 | 1540.4 |
流動負債總額 | 2742.1 | 2142 | 1877.53 | 1334.83 | 1120.29 |
應付賬款 | 303.9 | 195 | 155.139 | 87.61 | 110.987 |
預提費用 | 2052 | 1500.6 | 1311.32 | 1056.12 | 604.495 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 40.8 | 46.9 | 42.434 | 30.293 | 9.817 |
其他流動負債,總計 | 345.4 | 399.5 | 368.641 | 160.801 | 394.993 |
負債總額 | 4238.2 | 3332.5 | 3064.99 | 2233.22 | 1810.69 |
長期債務總額 | 430.8 | 509.8 | 539.042 | 538.576 | 581.55 |
長期債務 | |||||
資本租賃義務 | 430.8 | 509.8 | 539.042 | 538.576 | 581.55 |
遞延所得稅 | 0 | ||||
少數股權 | 0 | ||||
其他負債,總計 | 1065.3 | 680.7 | 648.418 | 359.818 | 108.853 |
股權 | 13912.7 | 10100 | 8686.82 | 6085.24 | 4435.2 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
普通股 | 2.6 | 2.5 | 2.599 | 2.589 | 2.546 |
額外實收資本 | 7386.5 | 6880.8 | 7894.03 | 7937.61 | 7421.48 |
留存收益(累計赤字) | 6522.8 | 3200.8 | 858.669 | -1852.98 | -2989.48 |
Unrealized Gain (Loss) | -0.1 | -0.5 | 0.334 | 0.503 | -0.536 |
其他權益,總計 | 0.9 | 16.4 | -68.814 | -2.476 | 1.195 |
總負債和股東權益 | 18150.9 | 13432.5 | 11751.8 | 8318.46 | 6245.9 |
已發行普通股總數 | 257.012 | 254.479 | 259.89 | 258.993 | 255.172 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 14695.8 | 13872.9 | 12965.7 | 13234.8 | 12271 |
現金和短期投資 | 11928.2 | 11236.3 | 10414.1 | 10778.5 | 9770.7 |
現金等價物 | 11110.2 | 10151.1 | 9289.9 | 10504 | 9171.5 |
短期投資 | 818 | 1085.2 | 1124.2 | 274.5 | 599.2 |
應收賬款總額,淨額 | 1538.7 | 1556.2 | 1547.8 | 1442.2 | 1385.2 |
應收賬款 - 貿易,淨額 | 1538.7 | 1556.2 | 1547.8 | 1442.2 | 1385.2 |
總庫存 | 688.7 | 603.5 | 535.1 | 460.6 | 388.2 |
預付的費用 | 502.4 | 470.1 | 449.2 | 553.5 | 535.3 |
其他流動資産,總計 | 37.8 | 6.8 | 19.5 | 191.6 | |
總資産 | 21726.2 | 20349.2 | 18974.2 | 18150.9 | 16706.4 |
物業/廠房/設備,總計 - 淨額 | 1434.5 | 1446.7 | 1448 | 1455.8 | 1461.4 |
商譽,淨額 | 1088 | 1088 | 1088 | 1088 | 1075.2 |
無形資産,淨額 | 603.6 | 603.6 | 603.6 | 603.6 | 603.6 |
長期投資 | 1798.6 | 1455.9 | 1180.1 | 98.6 | 98.6 |
其他長期資産,總計 | 2105.7 | 1882.1 | 1688.8 | 1670.1 | 1196.6 |
流動負債總額 | 3599.4 | 3352.1 | 3026.2 | 2742.1 | 2609.3 |
應付賬款 | 375.9 | 363 | 323.2 | 303.9 | 126.9 |
預提費用 | 2907.3 | 2598.1 | 2326 | 2126.7 | 2264.4 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 316.2 | 391 | 377 | 311.5 | 218 |
負債總額 | 5213.4 | 4879 | 4541.9 | 4238.2 | 3676.8 |
長期債務總額 | 390.3 | 404.1 | 417.6 | 430.8 | 442.3 |
資本租賃義務 | 390.3 | 404.1 | 417.6 | 430.8 | 442.3 |
其他負債,總計 | 1223.7 | 1122.8 | 1098.1 | 1065.3 | 625.2 |
股權 | 16512.8 | 15470.2 | 14432.3 | 13912.7 | 13029.6 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
普通股 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 |
額外實收資本 | 7339.6 | 7369.1 | 7220.2 | 7386.5 | 7225.5 |
留存收益(累計赤字) | 9173.6 | 8138.3 | 7222.6 | 6522.8 | 5703.9 |
Unrealized Gain (Loss) | -18.9 | -12.7 | 2.8 | -0.1 | -4.1 |
其他權益,總計 | 15.9 | -27.1 | -15.9 | 0.9 | 101.7 |
總負債和股東權益 | 21726.2 | 20349.2 | 18974.2 | 18150.9 | 16706.4 |
已發行普通股總數 | 257.829 | 257.793 | 257.51 | 257.012 | 256.646 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | 3322 | 2342.1 | 2711.65 | 1176.81 | 2087.1 |
經營活動産生的現金 | 4129.9 | 2643.5 | 3253.5 | 1569.33 | 1270.29 |
經營活動産生的現金 | 148.3 | 125.6 | 109.515 | 106.941 | 72.42 |
Deferred Taxes | -275.9 | -154.6 | 277.341 | 167.387 | -1512.32 |
非現金物品 | 594.7 | 435.6 | 209.456 | 184.293 | 385.068 |
Cash Taxes Paid | 1057.8 | 476.3 | 191.776 | 24.73 | 12.402 |
已付現金利息 | 52.3 | 56.3 | 54.52 | 55.554 | 66.458 |
營運資金的變化 | 340.8 | -105.2 | -54.454 | -66.101 | 238.02 |
投資活動産生的現金 | -321.1 | -340.9 | 99.388 | -1235.32 | -202.158 |
資本支出 | -204.7 | -235 | -259.798 | -75.451 | -95.524 |
其他投資現金流量項目,總計 | -116.4 | -105.9 | 359.186 | -1159.87 | -106.634 |
融資活動産生的現金 | -67.7 | -1478 | -505.281 | 126.773 | -71.219 |
融資現金流項目 | -168.5 | -130.2 | -202.067 | 4.683 | 2.079 |
股票的發行(報廢),淨額 | 186.3 | -1323.4 | -274.19 | 151.229 | -60.75 |
債務的發行(退還),淨額 | -85.5 | -24.4 | -29.024 | -29.139 | -12.548 |
外彙效應 | -29.2 | -13.4 | 20.552 | 1.643 | -6.182 |
現金淨變化 | 3711.9 | 811.2 | 2868.16 | 462.428 | 990.727 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 699.8 | 3322 | 2503.1 | 1572.6 | 762.1 |
Cash From Operating Activities | 899.9 | 4129.9 | 3051.5 | 2096 | 956.2 |
Cash From Operating Activities | 38.8 | 148.3 | 109.9 | 73.2 | 35.9 |
Deferred Taxes | -113.4 | -275.9 | -424 | -241.7 | -12.3 |
Non-Cash Items | 135.8 | 594.7 | 430.8 | 341 | 203.3 |
Cash Taxes Paid | 120.3 | 1057.8 | 840.1 | 478.3 | 85 |
Cash Interest Paid | 11.1 | 52.3 | 41.1 | 27.1 | 13.7 |
Changes in Working Capital | 138.9 | 340.8 | 431.7 | 350.9 | -32.8 |
Cash From Investing Activities | -1833.6 | -321.1 | -496.7 | -112.5 | -51 |
Capital Expenditures | -42.1 | -204.7 | -171.1 | -116.9 | -63.6 |
Other Investing Cash Flow Items, Total | -1791.5 | -116.4 | -325.6 | 4.4 | 12.6 |
Cash From Financing Activities | -294.7 | -67.7 | -107.9 | -47.7 | -95.4 |
Financing Cash Flow Items | -165.5 | -168.5 | -167.5 | -120.2 | -116.2 |
Issuance (Retirement) of Stock, Net | -118.6 | 186.3 | 134.7 | 98.1 | 33.7 |
Issuance (Retirement) of Debt, Net | -10.6 | -85.5 | -75.1 | -25.6 | -12.9 |
Foreign Exchange Effects | 12 | -29.2 | -70 | -31.8 | -5.9 |
Net Change in Cash | -1216.4 | 3711.9 | 2376.9 | 1904 | 803.9 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
50 Northern Avenue
BOSTON
MASSACHUSETTS 02210
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易